PHOENIX, Ariz. – May 21, 2012 –

Share

Combined expertise accelerated development cycle of the CVRx Barostim neo™ – a second-generation, low-power, implantable device

PHOENIX, Ariz. – May 21, 2012 – ON Semiconductor (Nasdaq: ONNN), a premier supplier of high- performance silicon solutions for energy efficient electronics, announced today that CVRx, a market-leading developer of proprietary active implantable technology to treat high blood pressure, is using its technology and manufacturing services. CVRx recently launched the Barostim neo™ – the company’s second-generation implantable anti-hypertensive barostimulation device – in Europe.

ON Semiconductor’s extensive experience in designing and manufacturing analog, digital and mixed-signal semiconductor solutions for a wide range of medical applications helped CVRx achieve the required reliability and device performance during extensive pre-production testing. In addition, the use of ON Semiconductor design kits and intellectual property, as well as its layout and foundry services, compressed the development cycle.

The Barostim neo contains three ON Semiconductor devices. Two custom application-specific integrated circuits (ASICs) include a high-voltage analog C5 process device and a digital control ASIC manufactured using ON Semiconductor’s I3T process, which supports digital integration, combined with mixed analog and smart power high-voltage structures. Also housed within the compact Barostim neo is an ON Semiconductor 8 megabit medical memory ASSP. All three devices achieve low-power operation to support long operational life – a key requirement for implantable medical devices.

“Our selection of ON Semiconductor for the development of our latest implantable device for treating hypertension has had multiple benefits,” said Joe DuPay, vice president of Research & Development and Operations, CVRx, Inc. “By combining our own core expertise with ON Semiconductor’s knowledge, experience and product longevity support in the demanding medical semiconductor market, we shortened the product development cycle while setting the highest standards in very low-power, reliable design.”

About CVRx

CVRx, Inc. is a private company and is headquartered in Minneapolis. The company has developed the Barostim neo for the treatment of high blood pressure and heart failure. For more information, visit www.cvrx.com.

About onsemi

onsemi (Nasdaq: ON) is driving disruptive innovations to help build a better future. With a focus on automotive and industrial end-markets, the company is accelerating change in megatrends such as vehicle electrification and safety, sustainable energy grids, industrial automation, and 5G and cloud infrastructure. With a highly differentiated and innovative product portfolio, onsemi creates intelligent power and sensing technologies that solve the world’s most complex challenges and leads the way in creating a safer, cleaner, and smarter world.

###

onsemi and the onsemi logo are trademarks of Semiconductor Components Industries, LLC. All other brand and product names appearing in this document are registered trademarks or trademarks of their respective holders. Although the Company references its website in this news release, information on the website is not to be incorporated herein.

If you are a member of the press and are interested in receiving onsemi press releases via email, please complete the form below.

* Full Name

* Email

* Media you represent

* Press Category

*Required fields

Choose your prefered language. You can choose more than one.